BrainCool

BrainCool™ System offers precision temperature management of the body, for example, to improve survival and reduce permanent disability in people suffering from sudden cardiac arrest or stroke. The system utilizes cooling pads designed for minimal discomfort to reach target temperatures. Furthermore, the cooling pads can be repositioned during treatment, which decreases the risk of skin damage and lessens the workload for hospital staff. As the number of operating systems in clinics grows, the continuous use of pads leads to increasing revenues over time. In 2024, BrainCool supplied nearly 10,000 consumables, compared to around 5,500 in 2023.

“We are encouraged that the cooperation with ZOLL® continues to develop according to plan. The orders presented today clearly signal that the BrainCool™ Systems in place at hospitals are being incorporated into clinical practice and that hospital staff are confident in the clinical benefit they provide. Furthermore, we are glad to have received additional orders from South Korea and Vietnam, as we see great potential in the commercial growth also in this region,” said Jon Berg, CEO of BrainCool.